THOMAS RYAN GULLATT MD
Prescription History 1750701421
Internal Medicine - Clinical Cardiac Electrophysiology in Baton Rouge, LA

NPI Status: Active since April 22, 2014

Contact Information

8401 PICARDY AVE
BATON ROUGE, LA
ZIP 70809
Phone: (225) 308-0247
Fax: (225) 308-0249

Get Directions

Prescription History for Informed Healthcare Decisions

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for THOMAS RYAN GULLATT MD, an active Clinical Cardiac Electrophysiology specialist practicing in Baton Rouge, LA. Our medical registry currently tracks 7 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 213 documented patient claims. Among these therapy options, the most frequently utilized medication is Eliquis, which accounts for 80 claims alone.


Amiodarone Hcl

Generic Formulation: Amiodarone HclSpecialty: Clinical Cardiac Electrophysiology
Provider Metrics Summary
Total Claims 15
30-Day Fills 35.4
Days Supply 1,062
LA State Average Benchmarks
Peer Average Claims49.0
Peer Average 30-Day Fills91.9
Peer Average Days Supply2,697
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 69.4% less volume than the regional standard for practitioners inside LA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $741.97 across this reporting matrix range.

Provider Avg Cost Per Claim

$49.46

State Avg Cost Per Claim

$25.75

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is used to treat certain types of serious (possibly fatal) irregular heartbeat (such as recurrent ventricular fibrillation/tachycardia). It is used to restore normal heart rhythm and maintain a regular, steady heartbeat. Amiodarone is known as an anti-arrhythmic drug. It works by blocking certain electrical signals in the heart that can cause an irregular heartbeat.

Doxycycline Hyclate

Generic Formulation: Doxycycline HyclateSpecialty: Clinical Cardiac Electrophysiology
Provider Metrics Summary
Total Claims 44
30-Day Fills 44.0
Days Supply 225
LA State Average Benchmarks
Peer Average Claims33.0
Peer Average 30-Day Fills34.8
Peer Average Days Supply461
Elevated Utilization

This provider maintains an active emphasis on this therapeutic option, recording 33.3% more claims than the standard regional baseline profile for LA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $232.73 across this reporting matrix range.

Provider Avg Cost Per Claim

$5.29

State Avg Cost Per Claim

$18.66

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A synthetic tetracycline derivative with similar antimicrobial activity.

Therapeutic Applications

This medication is used to treat a wide variety of bacterial infections, including those that cause acne. This medication is also used to prevent malaria. This medication is known as a tetracycline antibiotic. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections.

Eliquis

Generic Formulation: ApixabanSpecialty: Clinical Cardiac Electrophysiology
Provider Metrics Summary
Total Claims 80
30-Day Fills 91.5
Days Supply 2,740
LA State Average Benchmarks
Peer Average Claims97.0
Peer Average 30-Day Fills135.5
Peer Average Days Supply3,768
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across LA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $54,765.77 across this reporting matrix range.

Provider Avg Cost Per Claim

$684.57

State Avg Cost Per Claim

$714.93

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Apixaban is used to prevent serious blood clots from forming due to a certain irregular heartbeat (atrial fibrillation) or after hip/knee replacement surgery. With atrial fibrillation, part of the heart does not beat the way it should. This can lead to blood clots forming, which can travel to other parts of your body (such as the lungs or legs) or increase your risk for stroke. In the United States, apixaban is also approved to treat certain types of blood clots (deep vein thrombosis-DVT, pulmonary embolus-PE) and to prevent them from forming again. Apixaban is an anticoagulant that works by blocking certain clotting proteins in your blood.

Flecainide Acetate

Generic Formulation: Flecainide AcetateSpecialty: Clinical Cardiac Electrophysiology
Provider Metrics Summary
Total Claims 16
30-Day Fills 25.5
Days Supply 766
LA State Average Benchmarks
Peer Average Claims47.0
Peer Average 30-Day Fills93.6
Peer Average Days Supply2,787
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 66.0% less volume than the regional standard for practitioners inside LA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $566.64 across this reporting matrix range.

Provider Avg Cost Per Claim

$35.42

State Avg Cost Per Claim

$58.62

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A potent anti-arrhythmia agent, effective in a wide range of ventricular and atrial ARRHYTHMIAS and TACHYCARDIAS.

Therapeutic Applications

This medication is used to treat certain types of serious (possibly fatal) irregular heartbeat (such as sustained ventricular tachycardia and paroxysmal supraventricular tachycardia). It is used to restore normal heart rhythm and maintain a regular, steady heartbeat. It is also used to prevent certain types of irregular heartbeat from returning (such as atrial fibrillation). Flecainide is known as an anti-arrhythmic drug. It works by blocking certain electrical signals in the heart that can cause an irregular heartbeat. Treating an irregular heartbeat can decrease the risk for blood clots, and this effect can reduce your risk of heart attack or stroke. Older adults should discuss the risks and benefits of this medication with their doctor or pharmacist, as well as other effective and possibly safer treatments.

Metoprolol Succinate

Generic Formulation: Metoprolol SuccinateSpecialty: Clinical Cardiac Electrophysiology
Provider Metrics Summary
Total Claims 25
30-Day Fills 55.5
Days Supply 1,665
LA State Average Benchmarks
Peer Average Claims122.0
Peer Average 30-Day Fills270.9
Peer Average Days Supply8,064
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 79.5% less volume than the regional standard for practitioners inside LA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $602.14 across this reporting matrix range.

Provider Avg Cost Per Claim

$24.09

State Avg Cost Per Claim

$16.10

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS.

Therapeutic Applications

This medication is a beta-blocker used to treat chest pain (angina), heart failure, and high blood pressure. Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. This drug works by blocking the action of certain natural chemicals in your body (such as epinephrine) that affect the heart and blood vessels. This lowers heart rate, blood pressure, and strain on the heart.

Pantoprazole Sodium

Generic Formulation: Pantoprazole SodiumSpecialty: Clinical Cardiac Electrophysiology
Provider Metrics Summary
Total Claims 22
30-Day Fills 24.0
Days Supply 720
LA State Average Benchmarks
Peer Average Claims111.0
Peer Average 30-Day Fills214.8
Peer Average Days Supply6,345
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 80.2% less volume than the regional standard for practitioners inside LA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $135.31 across this reporting matrix range.

Provider Avg Cost Per Claim

$6.15

State Avg Cost Per Claim

$12.80

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

2-pyridinylmethylsulfinylbenzimidazole proton pump inhibitor that is used in the treatment of GASTROESOPHAGEAL REFLUX and PEPTIC ULCER.

Therapeutic Applications

Pantoprazole is used to treat certain stomach and esophagus problems (such as acid reflux). It works by decreasing the amount of acid your stomach makes. This medication relieves symptoms such as heartburn, difficulty swallowing, and cough. It helps heal acid damage to the stomach and esophagus, helps prevent ulcers, and may help prevent cancer of the esophagus. Pantoprazole belongs to a class of drugs known as proton pump inhibitors (PPIs).

Sucralfate

Generic Formulation: SucralfateSpecialty: Clinical Cardiac Electrophysiology
Provider Metrics Summary
Total Claims 11
30-Day Fills 11.0
Days Supply 327
LA State Average Benchmarks
Peer Average Claims35.0
Peer Average 30-Day Fills47.0
Peer Average Days Supply1,252
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 68.6% less volume than the regional standard for practitioners inside LA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $383.73 across this reporting matrix range.

Provider Avg Cost Per Claim

$34.88

State Avg Cost Per Claim

$61.51

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A basic aluminum complex of sulfated sucrose.

Therapeutic Applications

This medication is used to treat ulcers in the intestines. Sucralfate forms a coating over ulcers, protecting the area from further injury. This helps ulcers heal more quickly.

Dataset Methodology & CMS Source Information

This analytical profile maps public infrastructure records sourced directly from official **Centers for Medicare & Medicaid Services (CMS)** public data releases. The statistics above track documented pharmaceutical treatment trends assigned to beneficiaries specifically under federal public programs. Evaluating the prescriptive footprints of clinical practitioners like THOMAS RYAN GULLATT MD provides transparency into local medical care patterns within Baton Rouge, LA.

Key Learning Objectives for this Profile:

  • Prescribing Frequencies: Track and evaluate the volume metrics of specific brand-name and generic medical formulas chosen by this provider over time.
  • Clinical Focus Areas: Identify how the provider distributes therapeutic selections across medical care options to gain insight into their true day-to-day **Clinical Cardiac Electrophysiology** practice concentrations.
  • Program Cost Awareness: Review the calculated total systemic drug costs and raw transactional volumes linked to these orders to better anticipate network insurance coverage structures.
  • Patient-Centered Evaluation: Cross-reference localized regional care comparisons to align practitioner habits directly with your proactive health maintenance goals.

Data Scope Exclusion & Limitations: The data elements presented above explicitly reflect prescription orders processed for Medicare beneficiaries during the year 2023. This informational profile does not aggregate prescription data for individuals utilizing private commercial health plans, state Medicaid coverage, or self-pay options. However, because medical decision-making remains highly consistent across clinical settings, this public registry provides a reliable proxy for understanding the general prescribing preferences and pharmaceutical care approach used by this provider.